[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.145.232.99. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
February 1985

Escherichia coli and Human NeutrophilsEffect of Bacterial Supernatant With Hemolysin Activity Upon Chemotaxin Receptors

Author Affiliations

From the Department of Surgery, University of Minnesota School of Medicine, Minneapolis (Drs Pruett, Nelson, and Simmons, and Mr Fiegel) and the Department of Pathology, Veterans Administration Medical Center, University of California at San Diego (Dr Chenoweth). Dr Chenoweth is currently a clinical investigator with the Veterans Administration.

Arch Surg. 1985;120(2):212-216. doi:10.1001/archsurg.1985.01390260072010
Abstract

• A greater proportion of Escherichia coli strains isolated from clinical extraintestinal infections produce α-hemolysin than do strains isolated from normal fecal flora. Proposed mechanisms to explain this observation have stressed the fact that hemolysis liberates hemoglobin, which may provide a nutritional boost for E coli growth. Alternatively, a cytolytic effect of hemolysin upon host neutrophils has been postulated. Our previous studies have suggested a third possibility: Human neutrophils incubated in the supernatant of an α-hemolysin—producing E coli strain produced a selective inhibition of chemotaxis toward C5a. Bacteria-free supernatants from 14 clinical strains of E coli were therefore evaluated for an ability to lyse sheep erythrocytes, alter human polymorphonuclear neutrophil (PMN) chemotaxin receptors, and affect release of PMN enzymes. Supernatants possessing hemolytic activity decreased the C5a receptor activity of human PMNs and increased the number of peptide receptors. A stimulation of secondary granule release, as evidenced by the release of PMN lysozyme, may account for the increased expression of peptide receptors. Perturbation of host defenses through a loss of neutrophil migratory function and secondary granule contents may allow for enhanced survival of E coli, which produce α-hemolysin.

(Arch Surg 1985;120:212-216)

References
1.
Fried FA, Wong RJ:  Etiology of pyelonephritis: Significance of hemolytic Escherichia coli . J Urol 1970;103:718-721.
2.
Minshew BH, Jorgenson J, Swanstrum M, et al:  Some characteristics of Escherichia coli strains isolated from extraintestinal infections of humans . J Infect Dis 1978;137:648-654.Article
3.
Brooks HJL, Grady FO, McSherry MA, et al:  Uropathogenic properties of Escherichia coli in recurrent urinary tract infection . J Med Microbiol 1980;13:57-68.Article
4.
Silver RP, Finn CW, Vann WF, et al:  Molecular cloning of the K1 capsular polysaccharide genes of E coli . Nature 1981;289:696-698.Article
5.
Smith HW, Huggins MB:  The association of the 018, K1 and H7 antigens and the Col V plasmid of a strain of Escherichia coli with its virulence and immunogenicity . J Gen Microbiol 1980;121:387-400.
6.
Williams PH:  Novel iron uptake system specified by Col V plasmids: An important component in the virulence of invasive strains of Escherichia coli . Infect Immun 1979;26:925-932.
7.
Waalwijk C, MacLaren DM, DeGraaff J:  In vivo function of hemolysin in the nephropathogenicity of Escherichia coli . Infect Immun 1983;42: 245-249.
8.
Cavalieri SJ, Snyder IS:  Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte viability in vitro . Infect Immun 1982;36:455-461.
9.
Cavalieri SJ, Snyder IS:  Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte function in vitro . Infect Immun 1982;37:966-974.
10.
Pruett TL, Rotstein OD, Fiegel VD, et al:  Mechanism of the adjuvant effect of hemoglobin in experimental peritonitis: VIII. A leukotoxin is produced by E coli metabolism in hemoglobin . Surgery 1984;96:375-383.
11.
Nelson RD, Fiegel VD, Chenoweth DE:  Human neutrophil peptide receptors: Mobilization mediated by phospholipase C . Am J Pathol 1982;107: 202-211.
12.
Ferrante A, Thong YH:  A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique . J Immunol Methods 1978;24: 389-393.Article
13.
Short EC, Kurtz HJ:  Properties of the hemolytic activities of Escherichia coli . Infect Immun 1971;3:678-687.
14.
Fernández HN, Hugli TE:  Partial characterization of human C5a anaphyllatoxin: I. Chemical description of the carbohydrate and polypeptide portions of human C5a . J Immunol 1976;117:1688-1694.
15.
Chenoweth DE, Hugli TE:  Demonstration of a specific C5a receptor on intact human polymorphonuclear leukocytes . Proc Nati Acad Sci USA 1978;75:3943-3947.Article
16.
Nelson RD, Fiegel VD, Herron MJ, et al:  Chemotactic deactivation of human neutrophils: Relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon . J Reticuloendothel Soc 1980;28:285-294.
17.
Scatchard G:  The attractions of proteins for small molecules and ions . Ann NY Acad Sci 1949;51:660-672.Article
18.
Altemeier WA, Culbertson WR, Fullen WD, et al:  Intra-abdominal abscesses . Am J Surg 1973;125:70-79.Article
19.
Salit IE, Gotschlich EC:  Type I Escherichia coli pili: Characterization of binding to monkey kidney cells . J Exp Med 1977;146:1182-1194.Article
20.
Cooke EM, Ewins SP:  Properties of strains of Escherichia coli isolated from a variety of sources . J Med Microbiol 1975;8:107-111.Article
21.
Welch RA, Falkow S:  Characterization of Escherichia coli hemolysins conferring quantitative differences in virulence . Infect Immun 1984;43: 156-160.
22.
Goebel W, Springer W:  Synthesis and secretion of hemolysin by Escherichia coli . J Bacteriol 1980;144:53-59.
23.
Boe NM, Dellinger EP, Minshew BH:  Effect of clindamycin on growth and hemolysin production by Escherichia coli . J Antimicrob Chemother 1983;12( (suppl C) ):105-116.Article
×